Author:
Nicholson R. I.,Giles M. G.,Hutcheson I. R.,Madden T.,Gee J. M. W.
Abstract
This article examines the experimental and clinical evidence of the effect of growth factor signalling in an attempt to reconcile the seeming paradox of, on the one hand, evidence that growth factor signalling can facilitate the activity of oestrogen receptor-α (ER-α), and on the other hand, evidence that extreme growth factor signalling can promote loss of ER function and expression, thereby promoting an endocrine insensitive and ultimately ER− phenotype. The results of this analysis lead to the therapeutic possibility that ER negativity may, in some instances, be reversible to generate endocrine response and improve patient prognosis.
Publisher
Cambridge University Press (CUP)
Subject
Cancer Research,Oncology(nursing),Oncology
Reference35 articles.
1. Yan L , Nass SJ , Smith D , Nelson WG , Herman JG , Davidson NE . Specific inhibition of DNMT1 by antisense oligonucleotides induces re-expression of estrogen receptor-alpha (ER) in ER-negative human breast cancer cell lines. Cancer Biol Ther 2003; 2: 552–556.
2. Munzone E , Nole F , Renne G , Balduzzi A , Sanna G , Corsetto L , Goldhirsch A . Reverting estrogen receptor (ER) negative phenotype in advanced breast cancer patients over-expressing HER2 after treatment with trastuzumab plus chemotherapy. Proc Am Soc Clin Oncol 2003; 22: 848 [Abstract 3409].
3. Badia E , Duchesne MJ , Semlali A , Fuentes M , Giamarchi C , Richard-Foy H , Nicolas JC Pons M . Long-term hydroxytamoxifen treatment of an MCF-7-derived breast cancer cell line irreversibly inhibits the expression of estrogenic genes through chromatin remodeling. Cancer Res 2000; 60: 4130–4138.
4. Mazumdar A , Wang RA , Mishra SK , Adam L , Bagheri-Yarmand R , Mandal, M , Vadlamudi RK , Kumar R . Transcription repression of oestrogen receptor by metastasis-associated protein 1 corepressor. Nat Cell Biol 2001; 3: 30–37.
5. Alcock RA , Dey S , Chendil D , Inayat MS , Mohiuddin M , Hartman G , Chatfield LK , Gallicchio VS , Ahmed MM . Farnesyltransferase inhibitor (l-744,832) restores TGF-beta type II receptor expression and enhances radiation sensitivity in K-ras mutant pancreatic cancer cell line MIA PaCa-2. Oncogene 2002; 21: 7883–7890.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献